Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call

Tipranks - Tue Mar 31, 10:40AM CDT

End of Quarter Sale - 50% Off TipRanks

Bausch + Lomb Corporation ( (BLCO) ) has shared an announcement.

Bausch + Lomb Corporation will report its first-quarter 2026 financial results on April 29, 2026, and will host a conference call and live webcast at 8 a.m. ET to discuss the figures and provide a broader business update. The company will post related materials in its Investor Relations section, enabling analysts and shareholders to review financial performance and strategic developments, underscoring ongoing transparency and engagement with the investment community.

The most recent analyst rating on (BLCO) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.

Spark’s Take on BLCO Stock

According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.

The score is most constrained by weak financial performance—multi-year net losses and negative free cash flow—despite solid revenue growth and a supportive balance sheet in the latest period. Offsetting this, the earnings call was strong with clear 2026 guidance for improved margins and EBITDA growth, and the technical setup is constructive with the stock trending above key moving averages. Valuation is held back by negative earnings and no stated dividend support.

To see Spark’s full report on BLCO stock, click here.

More about Bausch + Lomb Corporation

Bausch + Lomb Corporation is a leading global eye health company focused on helping people see better. Its portfolio spans contact lenses, prescription eye-care products, over-the-counter treatments and surgical devices, serving patients and eye-care professionals worldwide through innovation and a strong commitment to improving standards of care.

Average Trading Volume: 410,086

Technical Sentiment Signal: Sell

Current Market Cap: $5.45B

Learn more about BLCO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.